Guggenheim Capital LLC Amarin Corp Plcuk Transaction History

Guggenheim Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$3.64 - $7.76 $2.01 Million - $4.29 Million	-552,895 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $1.89 Million - $3.27 Million	395,716 Added 251.76%	552,895 $3.83 Million
Q1 2020 Jun 02, 2020	SELL	$4.0 - $21.53 $145,212 - $781,603	-36,303 Reduced 18.76%	157,179 $629,000
Q4 2019 Feb 14, 2020	BUY	$13.94 - $24.12 $721,604 - $1.25 Million	51,765 Added 36.53%	193,482 $4.15 Million
Q3 2019 Nov 14, 2019	SELL	$13.89 - $23.16 $61,296 - $102,205	-4,413 Reduced 3.02%	141,717 $2.15 Million

Q2 2019 Aug 14, 2019	SELL	$16.27 - $20.51 $461,254 - $581,458	-28,350 Reduced 16.25%	146,130 $2.83 Million
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $2.2 Million - $3.9 Million	174,480 New	174,480 $3.62 Million

184

87.9M

528K

219K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $278M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.